ErbB2 Positive Metastatic Breast Cancer

NCT01658358 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Lapatinib
DRUG: Lipo-Dox

Sponsor

China Medical University Hospital